Search Ontology:
ChEBI
nateglinide
- Term ID
- CHEBI:31897
- Synonyms
-
- (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine
- A 4166
- A-4166
- AY 4166
- AY-4166
- AY4166
- Fastic
- N-[(trans-4-isopropylcyclohexyl)carbonyl]-D-phenylalanine
- nateglinida
- nateglinide
- nateglinidum
- Starlix
- Starsis
- trans-N-{[4-(1-methylethyl)cyclohexyl]carbonyl}-D-phenylalanine
- Definition
- An N-acyl-D-phenylalanine resulting from the formal condensation of the amino group of D-phenylalanine with the carboxy group of trans-4-isopropylcyclohexanecarboxylic acid. An orally-administered, rapidly-absorbed, short-acting insulinotropic agent, it is used for the treatment of type 2 diabetes mellitus.
- References
-
- cas:105816-04-4
- drugbank:DB00731
- drugcentral:1886
- hmdb:HMDB0014869
- kegg.compound:C12508
- kegg.drug:D01111
- patent:EP196222
- patent:US4816484
- pubmed:10820657
- pubmed:11585005
- pubmed:11724096
- pubmed:12652357
- pubmed:12918894
- pubmed:14748619
- pubmed:16178991
- pubmed:17253883
- pubmed:17573070
- pubmed:18200800
- pubmed:19337530
- pubmed:21801074
- pubmed:23229379
- pubmed:23675267
- pubmed:23867985
- pubmed:23872227
- pubmed:23935065
- pubmed:24563597
- wikipedia.en:Nateglinide
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from nateglinide
Phenotype where environments contain nateglinide
Phenotype modified by environments containing nateglinide
Phenotype affecting nateglinide
Human Disease Model